Diabetic Peripheral Neuropathy and the Management of Diabetic Peripheral Neuropathic Pain

References

• . Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007;8( suppl 2):S50–S62
   PubMed Web of Science ®Google Scholar
• . Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007;335(7610):87
   PubMed Web of Science ®Google Scholar
• . Dyck PJ, Kratz KM, Karnes JL, . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817–824
   PubMed Web of Science ®Google Scholar
• . Tesfaye S, Chaturvedi N, Eaton SE, . EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–350
   PubMed Web of Science ®Google Scholar
• . Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes. 1997;46( suppl 2):S54–A57
   PubMed Web of Science ®Google Scholar
• . Dyck PJ, Davies JL, Clark VM, . Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care. 2006;29(10):2282–2288
   PubMedGoogle Scholar
• . Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician. 2005;71(11):2123–2128
   PubMedGoogle Scholar
• . Tesfaye S, Boulton AJ, Dyck PJ, ; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293
   PubMed Web of Science ®Google Scholar
• . Dyck PJ, Albers JW, Andersen H, ; on behalf of the Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity [published online ahead of print June 21, 2011]. Diabetes Metab Res Rev.
   Google Scholar
• . Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553–1579
   PubMed Web of Science ®Google Scholar
• . Vinik AI, Mehrabyan A. Diagnosis and management of diabetic autonomic neuropathy. Compr Ther. 2003;29(2–3):130–145
   PubMedGoogle Scholar
• . Low PA, Benrud—Larson LM, Sletten DM, . Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27(12):2942–2947
   PubMed Web of Science ®Google Scholar
• . Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387–397
   PubMed Web of Science ®Google Scholar
• . Assessment: clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(3):873–880
   PubMedGoogle Scholar
• . Shakher J, Stevens MJ. Update on the management of diabetic polyneuropathies. Diabetes Metab Syndr Obes. 2011;4:289–305
   PubMedGoogle Scholar
• . Frykberg RG, Armstrong DG, Giurini J, . American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg. 2000;39( 5 suppl):S1–S60
   PubMedGoogle Scholar
• . Freeman R. Autonomic peripheral neuropathy. Lancet. 2005; 365(9466):1259–1270
   PubMed Web of Science ®Google Scholar
• . Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med. 2009;26(3):302–305
   PubMed Web of Science ®Google Scholar
• . Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24(7):1264–1269
   PubMed Web of Science ®Google Scholar
• . Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993;68(7):691–702
   PubMedGoogle Scholar
• . Hill SR, Fayyad AM, Jones GR. Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn. 2008;27(5):362–367
   PubMed Web of Science ®Google Scholar
• . Minhas S, Eardley I. Diabetes mellitus and impotence. In: Carson CC 3rd, Kirby RS, Goldstein I, Wyllie MG, eds. Textbook of Erectile Dysfunction. Oxford, England: Isis Medical Media; 1999:541–550
   Google Scholar
• . Várkonyi T, Kempler P. Erectile dysfunction. In: Sinclair A, ed. Diabetes in Old Age. Vol 3. New York, NY: John Wiley and Sons; 2009: 149–164
   Google Scholar
• . Fraser DM, Campbell IW, Ewing DJ, Clarke BF. Mononeuropathy in diabetes mellitus. Diabetes. 1979;28(2):96–101
   PubMed Web of Science ®Google Scholar
• . Boulton AJ, Vinik AI, Arezzo JC, . American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962
   PubMed Web of Science ®Google Scholar
• . Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med. 2009;10(8):1476–1480
   PubMedGoogle Scholar
• . Asbury AK. Proximal diabetic neuropathy. Ann Neurol. 1977;2(3): 179–180
   PubMed Web of Science ®Google Scholar
• . Vinik A, Mehrabyan A, Colen L, Boulton A. Focal entrapment neuropathies in diabetes. Diabetes Care. 2004;27(7):1783–1788
   PubMed Web of Science ®Google Scholar
• . Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care. 2006;29(4):883–887
   PubMedGoogle Scholar
• . Treede RD, Jensen TS, Campbell JN, . Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurolog y. 2008;70(18):1630–1635
   PubMed Web of Science ®Google Scholar
• . Ruhnau KJ, Meissner HP, Finn JR, . Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med. 1999;16(12):1040–1043
   PubMed Web of Science ®Google Scholar
• . Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21(2):114–121
   PubMedGoogle Scholar
• . Ziegler D, Hanefeld M, Ruhnau KJ, . Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995;38(12):1425–1433
   PubMed Web of Science ®Google Scholar
• . Vinik AI, Bril V, Kempler P, ; MBBQ Study Group. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther. 2005;27(8):1164–1180
   PubMedGoogle Scholar
• . Hotta N, Toyota T, Matsuoka K, ; SNK-860 Diabetic Neuropathy Study Group. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care. 2001;24(10):1776–1782
   PubMed Web of Science ®Google Scholar
• . Ziegler D, Ametov A, Barinov A, . Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365–2370
   PubMed Web of Science ®Google Scholar
• . Argoff CE, Backonja MM, Belgrade MJ, . Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc. 2006;81( 4 suppl):S12–S25
   PubMed Web of Science ®Google Scholar
• . Lindsay TJ, Rodgers BC, Savath V, Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician. 2010;82(2):151–158
   PubMed Web of Science ®Google Scholar
• . Diabetic peripheral neuropathic pain. Consensus guidelines for treatment. J Fam Pract. 2006;( suppl):3–19
   Google Scholar
• . Obrosova IG, Drel VR, Pacher P, . Oxidative-nitrosative stress and poly (ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes. 2005;54(12):3435–3441
   PubMed Web of Science ®Google Scholar
• . Apfel SC, Asbury AK, Bril V, . Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci. 2001;189(1–2):3–5
   PubMedGoogle Scholar
• . Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27(6):1458–1486
   PubMed Web of Science ®Google Scholar
• . Cruccu G, Anand P, Attal N, . EFNS guidelines on neuropathic pain assessment. Eur J Neurol. 2004;11(3):153–162
   PubMed Web of Science ®Google Scholar
• . Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454
   Google Scholar
• . Dworkin RH, O'Connor AB, Audette J, . Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85( 3 suppl):S3–S14
   PubMed Web of Science ®Google Scholar
• . Pape C, Haltenhof H. Tricyclic antidepressants in depressed patients with cardiovascular diseases: a contraindication [in German]? Psychiatr Prax. 1995;22(1):9–14
   PubMedGoogle Scholar
• . Hardy T, Sachson R, Shen S, Armbruster M, Boulton AJ. Does treatment with duloxetine for neuropathic pain impact glycemic control? Diabetes Care. 2007;30(1):21–26
   PubMed Web of Science ®Google Scholar
• . Chou R, Fanciullo GJ, Fine PG, ; American Pain Society—American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130
   PubMed Web of Science ®Google Scholar
• . Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis. 2001;3(2):53–62
   PubMedGoogle Scholar
• . Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houldren RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374(9697):1252–1261
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. CMRO. 2009;25(7):1677–1687
   Google Scholar
• . Selph S, Carson S, Fu R, Thakurta S, Low A, McDonagh M. Drug Class Review: Neuropathic Pain. Final Update 1 Report. Drug Class Reviews. Portland, OR: Oregon Health and Science University; 2011
   Google Scholar